Insulet (PODD)
(Delayed Data from NSDQ)
$194.38 USD
-2.38 (-1.21%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $194.51 +0.13 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Insulet Corporation [PODD]
Reports for Purchase
Showing records 301 - 320 ( 344 total )
Company: Insulet Corporation
Industry: Medical - Products
PODD Respectable Q4, better than expected 2012 revenue guidance, raising PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter...Super-high expectations with next-gen OmniPod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter...Super-high expectations with next-gen OmniPod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Q4 REVENUES ON-TRACK-LOSS SLIGHTLY HIGHER BUT OF LITTLE CONCERN-BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Bucking Headwinds - Three Medical Device Companies To Ride Into The New Year
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Strong Q3 Rev Growth Negatively Affected By Production Problem - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Respectable Q3 despite disruption, maintaining BUY but reducing PT to $18.60
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
The Truffle Shuffle-Diabetes Edition: Investment Implications of Obesity on Diabetes Devices
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S